Literature DB >> 26074209

The theoretical basis of minimally-invasive and non-invasive medicine: Treatments--Minimize harm to patients.

Zhibiao Wang1.   

Abstract

This perspective, for the first time, proposed the theoretical basis for the minimally-invasive and non-invasive medicine. It sets the goal of medical treatment that is to minimize harm to patients and to maximize the natural self-healing power for fighting against the disease. It took a historical review on the technological developments shaped by the minimally-invasive and non-invasive ideology with a focus on the course of research, development and clinical deployment of the high-intensity focused ultrasound (HIFU) ablation therapy by the Chinese research team. It also summarized the highlights of the "1st Yangtze International Summit of Minimally-invasive and Non-invasive Medicine 2013" and the mandate of the newly inaugurated International Society of the Minimally-invasive and Noninvasive Medicine (ISMINIM). It provides a perspective on the future development of this emerging field and its impact on human civilization.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIFU; Hysterectomy; Laparoscopic surgery; Minimally-invasive and non-invasive medicine; Treatments—minimize harm to patients; UAE

Mesh:

Year:  2015        PMID: 26074209     DOI: 10.1016/j.ultsonch.2015.05.023

Source DB:  PubMed          Journal:  Ultrason Sonochem        ISSN: 1350-4177            Impact factor:   7.491


  2 in total

1.  Multifunctional Nanoparticles Encapsulating Astragalus Polysaccharide and Gold Nanorods in Combination with Focused Ultrasound for the Treatment of Breast Cancer.

Authors:  Jie Xiong; Binglei Jiang; Yong Luo; Jianzhong Zou; Xuan Gao; Die Xu; Yan Du; Lan Hao
Journal:  Int J Nanomedicine       Date:  2020-06-12

2.  Effectiveness and safety of focused ultrasound ablation surgery compared with radiofrequency ablation in primary hepatocellular carcinoma treatment: a meta-analysis.

Authors:  Jian-Ying Zhang; Long Chen; Rong Ma; Chun-Mu Miao; Yun-Bing Wang
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.